Skip to main content


Latest articles

22-09-2017 | HBV | News | Article

High metabolic risk burden increases HCC risk in HBV patients

A high burden of metabolic risk factors significantly increases the risk for hepatocellular carcinoma among men with hepatitis B virus infection, particularly those who smoke, researchers from Taiwan report.


Gastroenterology 2017; Advance online publication

21-09-2017 | Oncology | News | Article


Bevacizumab biosimilar approved in USA

More details about this decision are just a click away

20-09-2017 | Oncology | News | Article

ESMO 2017 in brief

Cancer vigilance may be warranted for stroke survivors

Survivors of ischemic stroke are more likely to be diagnosed with cancer than the general population, a chart review suggests.

20-09-2017 | Lymphoma | Main feed | News


Copanlisib, low-dose cabazitaxel receive FDA go ahead

Click through to read more on these approvals

19-09-2017 | Oncology | News | Article

ESMO 2017 in brief

Abdominal fat linked to elevated cancer risk

Central obesity is associated with an increased incidence of cancer in postmenopausal women, according to research presented at the ESMO 2017 Congress in Madrid, Spain.

18-09-2017 | Non-small-cell lung cancer | News | Article

ESMO 2017

Dabrafenib–trametinib actively targets BRAF V600E-mutant metastatic NSCLC

Dabrafenib in combination with trametinib provides long-lasting antitumor activity in patients with previously untreated BRAF V600E-mutant metastatic non-small-cell lung cancer, with a tolerable safety profile, researchers report.


Lancet Oncol 2017; Advance online publication

image credits